Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

Zhang, Peng; Zhu, Lihua; Cai, Jingjing; Lei, Fang; Qin, Juan‐Juan; Xie, Jing; Liu, Ye-Mao; Zhao, Yan-Ci; Huang, Xuewei; Lin, Lijin; Meng, Xia; Chen, Mingming; Cheng, Xu; Zhang, Xiao; Guo, Deliang; Peng, Yuanyuan; Ji, Yan‐Xiao; Chen, Jing; She, Zhi‐Gang; Wang, Yibin; Xu, Qingbo; Tan, Renfu; Wang, Haitao; Lin, Jun; Luo, Pengcheng; Fu, Shouzhi; Cai, Hongbin; Ye, Ping; Xiao, Bing; Mao, Weiming; Liu, Li; Yan, Youqin; Liu, Mingyu; Chen, Manhua; Zhang, Xiao‐Jing; Wang, Xinghuan; M. Touyz, Rhian; Xia, Jiahong; Zhang, Binghong; Huang, Xiaodong; Yuan, Yufeng; Loomba, Rohit; P. Liu, Peter; Li, Hongliang

doi:10.1161/circresaha.120.317134

Public

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

Published in Circulation Research • Apr 17, 2020

Authors:

Peng Zhang

Lihua Zhu

Jingjing Cai

Abstract

Rationale: Use of ACEIs (angiotensin-converting enzyme inhibitors) and ARBs (angiotensin II receptor blockers) is a major concern for clinicians treating coronavirus disease 2019 (COVID-19) in patients with hypertension. Objective: To determine the association between in-hospital use of ACEI/ARB and...

Subject

Medicine

Interquartile range

Hazard ratio

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!